Cargando…
Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers
The field of single-cell analysis has advanced rapidly in the last decade and is providing new insights into the characterization of intercellular genetic heterogeneity and complexity, especially in human cancer. In this regard, analyzing single circulating tumor cells (CTCs) is becoming particularl...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369222/ https://www.ncbi.nlm.nih.gov/pubmed/35955517 http://dx.doi.org/10.3390/ijms23158386 |
_version_ | 1784766389942222848 |
---|---|
author | Khan, Tanzila Becker, Therese M. Po, Joseph W. Chua, Wei Ma, Yafeng |
author_facet | Khan, Tanzila Becker, Therese M. Po, Joseph W. Chua, Wei Ma, Yafeng |
author_sort | Khan, Tanzila |
collection | PubMed |
description | The field of single-cell analysis has advanced rapidly in the last decade and is providing new insights into the characterization of intercellular genetic heterogeneity and complexity, especially in human cancer. In this regard, analyzing single circulating tumor cells (CTCs) is becoming particularly attractive due to the easy access to CTCs from simple blood samples called “liquid biopsies”. Analysis of multiple single CTCs has the potential to allow the identification and characterization of cancer heterogeneity to guide best therapy and predict therapeutic response. However, single-CTC analysis is restricted by the low amounts of DNA in a single cell genome. Whole genome amplification (WGA) techniques have emerged as a key step, enabling single-cell downstream molecular analysis. Here, we provide an overview of recent advances in WGA and their applications in the genetic analysis of single CTCs, along with prospective views towards clinical applications. First, we focus on the technical challenges of isolating and recovering single CTCs and then explore different WGA methodologies and recent developments which have been utilized to amplify single cell genomes for further downstream analysis. Lastly, we list a portfolio of CTC studies which employ WGA and single-cell analysis for genetic heterogeneity and biomarker detection. |
format | Online Article Text |
id | pubmed-9369222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93692222022-08-12 Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers Khan, Tanzila Becker, Therese M. Po, Joseph W. Chua, Wei Ma, Yafeng Int J Mol Sci Review The field of single-cell analysis has advanced rapidly in the last decade and is providing new insights into the characterization of intercellular genetic heterogeneity and complexity, especially in human cancer. In this regard, analyzing single circulating tumor cells (CTCs) is becoming particularly attractive due to the easy access to CTCs from simple blood samples called “liquid biopsies”. Analysis of multiple single CTCs has the potential to allow the identification and characterization of cancer heterogeneity to guide best therapy and predict therapeutic response. However, single-CTC analysis is restricted by the low amounts of DNA in a single cell genome. Whole genome amplification (WGA) techniques have emerged as a key step, enabling single-cell downstream molecular analysis. Here, we provide an overview of recent advances in WGA and their applications in the genetic analysis of single CTCs, along with prospective views towards clinical applications. First, we focus on the technical challenges of isolating and recovering single CTCs and then explore different WGA methodologies and recent developments which have been utilized to amplify single cell genomes for further downstream analysis. Lastly, we list a portfolio of CTC studies which employ WGA and single-cell analysis for genetic heterogeneity and biomarker detection. MDPI 2022-07-29 /pmc/articles/PMC9369222/ /pubmed/35955517 http://dx.doi.org/10.3390/ijms23158386 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Khan, Tanzila Becker, Therese M. Po, Joseph W. Chua, Wei Ma, Yafeng Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers |
title | Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers |
title_full | Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers |
title_fullStr | Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers |
title_full_unstemmed | Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers |
title_short | Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers |
title_sort | single-circulating tumor cell whole genome amplification to unravel cancer heterogeneity and actionable biomarkers |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369222/ https://www.ncbi.nlm.nih.gov/pubmed/35955517 http://dx.doi.org/10.3390/ijms23158386 |
work_keys_str_mv | AT khantanzila singlecirculatingtumorcellwholegenomeamplificationtounravelcancerheterogeneityandactionablebiomarkers AT beckertheresem singlecirculatingtumorcellwholegenomeamplificationtounravelcancerheterogeneityandactionablebiomarkers AT pojosephw singlecirculatingtumorcellwholegenomeamplificationtounravelcancerheterogeneityandactionablebiomarkers AT chuawei singlecirculatingtumorcellwholegenomeamplificationtounravelcancerheterogeneityandactionablebiomarkers AT mayafeng singlecirculatingtumorcellwholegenomeamplificationtounravelcancerheterogeneityandactionablebiomarkers |